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a b s t r a c t
The vaccinia virion is a membraned, slightly ﬂattened, barrel-shaped particle, with a complex internal
structure featuring a biconcave core ﬂanked by lateral bodies. Although the architecture of the puriﬁed
mature virion has been intensely characterized by electron microscopy, the distribution of the proteins
within the virion has been examined primarily using biochemical procedures. Thus, it has been shown
that non-ionic and ionic detergents combined or not with a sulfhydryl reagent can be used to disrupt
virions and, to a limited degree, separate the constituent proteins in different fractions. Applying a
controlled degradation technique to virions adsorbed on EM grids, we were able to immuno-localize
viral proteins within the virion particle. Our results show after NP40 and DTT treatment, membrane
proteins are removed from the virion surface revealing proteins that are associated with the lateral
bodies and the outer layer of the core wall. Combined treatment using high salt and high DTT removed
lateral body proteins and exposed proteins of the internal core wall. Cores treated with proteases could
be disrupted and the internal components were exposed. Cts8, a mutant in the A3 protein, produces
aberrant virus that, when treated with NP-40 and DTT, releases to the exterior the virus DNA associated
with other internal core proteins. With these results, we are able to propose a model for the structure
the vaccinia virion.
Published by Elsevier Inc.
Introduction
Poxviridae comprise a family of viruses characterized by the
presence of a large dsDNA genome and a complex morphology
(Condit et al., 2006; Moss, 2013). Poxviruses encode a complete
transcription apparatus and thus are able to replicate in the
cytoplasm of infected cells. Vaccinia virus (VACV), the prototype
member of this family, encodes more than 200 proteins and the
role of many virus proteins during the virus replicative cycle has
been determined (Goebel et al., 1990; Moss, 2013). The protein
composition of puriﬁed mature virions has been determined by
mass spectrometry and at least 70 virus proteins have been
identiﬁed (Chung et al., 2006; Matson et al., 2014; Resch et al.,
2007; Yoder et al., 2006). Although the proteomic analysis has
been important for the identiﬁcation of the total protein content of
the mature particle, the ﬁne localization of a signiﬁcant fraction of
the virion proteins is still unknown. Membrane proteins and
enzymes involved in early transcription have been assigned
positions in the particle, but the location of the other proteins
still needs to be determined.
Electron microscopy is the preferred method for studying the
morphology of the VACV particle and various electron microscopic
techniques have been applied in the visualization of the virus
structure (Cyrklaff et al., 2005; Dales and Siminovith, 1961;
Easterbrook, 1966; Harris and Westwood, 1964; Ichihashi et al.,
1984; Muller and Peters, 1963; Naginton and Horne, 1962; Peters
and Muller, 1963; Westwood et al., 1964; Wilton et al., 1995).
Overall, poxvirus virions have an ellipsoidal, barrel or brick shaped
appearance. Analysis of VACV on a whole mount preparation using
negative staining of the particles revealed the presence of a
membrane that enclosed two distinct virus sub-domains: the
lateral bodies and the core (Dales, 1962; Harris and Westwood,
1964; Muller and Peters, 1963; Peters and Muller, 1963; Westwood
et al., 1964). The lateral bodies, which ﬂank the core, are amor-
phous structures composed of proteins of unknown function. The
core is comprised of a proteinaceous wall that encloses a nucleo-
capsid (Condit et al., 2006). Analysis of VACV by cryo-microscopy
and reconstruction using electron tomography revealed pore-like
structures spanning the core wall (Cyrklaff et al., 2005). No
function has been determined for this structure although it could
be involved in the extrusion from the core of the viral mRNA
during early transcription.
Using negative staining electron microscopy, the surface of the
mature virion presents two different morphological forms that are
directly related to the integrity of the particle. The predominant
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2014.11.020
0042-6822/Published by Elsevier Inc.
n Corresponding author.
E-mail address: nissin@uﬂ.edu (N. Moussatche).
Virology 475 (2015) 204–218
form in a fresh virion preparation contains on its surface rodlet-
like structures called surface tubule elements, creating a
mulberry-like appearance (Harris and Westwood, 1964; Muller
and Peters, 1963; Naginton and Horne, 1962; Westwood et al.,
1964; Wilton et al., 1995). Under various conditions, the negative
stain can penetrate through the virus membrane so that the
surface tubule elements are no longer apparent and the virus
now exhibits a capsule-like form. When virions are exposed to
high pH, the lateral bodies, core wall, and the nucleocapsid can be
visualized (Muller and Peters, 1963).
Analysis of VACV by atomic force microscopy has permitted a
more accurate determination of the dimensions of the virus
particle, because measurements are obtained with fully hydrated
virions (Malkin et al., 2003). Using this approach, the virus
dimensions vary between 320 and 380 nm in the major axis and
260 and 340 nm in the minor axis, similar to measurements
described by other methods (Cyrklaff et al., 2005; Grifﬁths et al.,
2001; Malkin et al., 2003; Roos et al., 1996; Sodeik and Krijnse-
Locker, 2002). However, the height of the hydrated virion varies
between 240 and 290 nm, a measurement signiﬁcantly higher
than what is observed with dried sample but similar from the
cryo-electron microscopy results.
Treatment of puriﬁed virions with a non-ionic detergent and a
reducing agent solubilizes the proteolipid membrane complex
exposing the core and the lateral bodies (Easterbrook, 1966;
Ichihashi et al., 1984). The soluble and insoluble components of
the virions can be separated by centrifugation and the protein
content of each fraction can be identiﬁed by various techniques
(Boyd et al., 2010; Chiu and Chang, 2002; Ichihashi et al., 1984;
Kato et al., 2007; Nichols et al., 2008; Resch and Moss, 2005;
Unger et al., 2008). Using this approach, proteins associated with
the membrane fractionate into the soluble fraction whereas the
insoluble fraction contains proteins from both the lateral bodies
and core. Puriﬁcation of the lateral bodies away from the core has
not been achieved using the current methodologies.
In this work, our goal was to develop a method to locate VACV
proteins in viral sub-domains. For this propose, we combined
whole mount preparation of virions with immunogold labeling of
the proteins. Virions attached to grids were subjected to various
treatments in order to expose viral proteins located in the different
sub-domains and permit their identiﬁcation by immunogold
labeling. Our results show after NP40 and DTT treatment, mem-
brane proteins such as A14 and A27 are removed from the virion
surface revealing proteins that are associated with the lateral
bodies and the outer layer of the core wall. Combined treatment
using high salt and high DTT removed lateral body proteins and
exposed proteins of the internal core wall. Cores treated with
proteases could be disrupted and the internal components were
exposed. Cts8, a mutant in the A3 protein, produces aberrant virus
that, when treated with NP-40 and DTT, releases to the exterior
the virus DNA associated with other internal core proteins. With
these results, we are able to propose a model for the structure the
vaccinia virion.
Results
Negative staining of vaccinia virus
The establishment of a standardized procedure to visualize
puriﬁed virions is an important step in the understanding viral
structure (De Carlo and Harris, 2011). Poxviruses were one of the
ﬁrst mammalian viruses to be visualized using electron micro-
scopic techniques. The structural analyses of puriﬁed VACV in
whole mount preparations revealed a unique pattern that has
been conﬁrmed by various procedures (Grifﬁths et al., 2001; Harris
and Westwood, 1964; Heuser, 2005; Malkin et al., 2003; Muller
and Peters, 1963; Westwood et al., 1964; Wilton et al., 1995). To
analyze the structure of puriﬁed VACV we used ﬁve different
negative staining conditions (Fig. 1). Similar to previous work
(Harris and Westwood, 1964; Muller and Peters, 1963; Peters and
Muller, 1963), when virions were negative-stained with phospho-
tungstic acid (PTA) at pH 7.0 particles could be visualized in two
different forms, the mulberry-like form and the capsule (Fig. 1A).
While the mulberry form shows a rodlet-like structure surround-
ing the particle, the capsule form presents a deﬁned frame that
surrounds the internal structure of the virion. When the pH of the
PTA solution was elevated to pH 10.5, only the capsule form was
observed, presumably because the integrity of the virion mem-
brane is compromised (Fig. 1B). Under these conditions, a tubular-
like internal structure of the virion was revealed that represents
the virus nucleocapsid (Muller and Peters, 1963). Virions in a
whole mount preparation were also negative-stained with ammo-
nium molybdate (AmMo), uranyl acetate (UA) and methylamine
tungstate (NanoW) (Fig. 1C–E). Under all these conditions, parti-
cles with a mulberry appearance were the major form observed.
When whole mount preparations of VACV were treated with the
neutral detergent NP40 before negative staining, a different
appearance of the particle was observed (Fig. 1F–J). In all prepara-
tions, because the lipid constituent of the virion membrane is
removed allowing stain to penetrate the particles, only the capsule
forms were observed and the core internal structure became
apparent. It is noteworthy that after this treatment the nucleo-
capsid appears amorphous, different from what was observed
when virions were stained with PTA at pH 10.5 (Fig. 1G). The
nucleocapsid is surrounded by a thick, well-deﬁned boundary
layer and the presence of the lateral bodies could be observed
(Fig. 1H). In some images, this boundary layer appears to be
formed by two thinner layers (Fig. 1F, H, and J). The outermost
layer is composed of a protein array that comprises proteins
involved in virion attachment, the entry-fusion complex and
structural membrane proteins. The internal layer includes the
spike-like “palisade layer” and additional core wall proteins
(Condit et al., 2006; Cyrklaff et al., 2005; Roos et al., 1996). The
majority of the proteins present in the outermost (membrane)
layer cannot be removed from the particle by NP40 treatment
alone (Chiu and Chang, 2002; Nichols et al., 2008). With this
treatment, the lipid component of the membrane is extracted and
virions lose their infectivity (Ichihashi and Oie, 1983; Laliberte and
Moss, 2009). Remarkably, the infectivity can be restored if the lipid
is replenished. After treatment of virus on the grids with NP40 and
DTT, the virion membrane, including the lipid and outer protein
array, is removed completely from the virion surface, so that the
boundary surrounding the core is reduced in thickness or even not
apparent in some of the electron micrographs (Fig. 1K–O).
Electron dense structures can be observed on the top of cores
stained with UA (Fig. 2A). Upon carbon–platinum shadowing of
these same samples, these structures present themselves in a
globular form and are presumed to be the lateral bodies (Fig. 2B).
Close inspection of particles treated with NP40þDTT and stained
with NanoW revealed pore-like structures with an average dia-
meter of 11.71 (71.25) on the surface of the core (Fig. 2C). The
presence of pore-like structures traversing the core wall has been
described, but the nature and function of these structures have yet
to be determined (Cyrklaff et al., 2005).
Importantly, the NP40-treated particles resemble virions in the
capsule form. Furthermore, both the capsule form and NP40
treated viruses are larger than the mulberry form of the particle.
Analysis of the two largest dimensions of the mulberry-like
viruses (n¼67) yielded 302.30 nm (722.92) for the long axis
and 240.90 nm (722.18) for the short axis. By contrast, the
dimensions of the capsule-like particles (n¼65) were 319.36 nm
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(719.65) and 251.67 nm (716.38), and the NP40-treated particles
(n¼76) were 323.50 nm (723.54) and 255.20 nm (18.14). The
difference in size between the mulberry-like and the other two
forms was statistically signiﬁcant with po0.01. These results are
in accordance with the literature (Westwood et al., 1964). Compar-
ing all the negative staining methods tested, the most consistent
Fig. 1. Negative staining of vaccinia virions. Vaccinia virions were adsorbed on a Formvar/carbon coated grid and incubated in the presence of Tris (A–E), NP-40 (F–J) or
NP-40þDTT (K–O). After 20 min the grids were washed and stained with PTA, pH 7.0 (A, F, K), PTA, pH 10.5 (B, G, L), AmMo (C, H, M), UA (D, I, N) or NanoW (E, J, O). The grids
were examined in a TEM as described in “Materials and methods”.
Fig. 2. Electron dense and pore-like structures on the surface of vaccinia core. Vaccinia cores were prepared on grids as described in Fig. 1. (A) Vaccinia core stained with UA
reveals an electro-dense structure in the middle of the particle. (B) A globular structure on the middle of the core was enhanced when the grid was subjected to platinum–
carbon shadowing. (C) The presence of pore-like structures (arrows) was observed after staining cores with NanoW.
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results were obtained with NanoW and UA, which we therefore
used for all subsequent experiments.
Immunogold labeling of vaccinia virus after controlled degradation
Our goal in this work was to localize viral proteins within
different sub-domains of the virion. Most of the current data
describing the location of viral proteins in different sub-domains
of the virion have been obtained using western blot analysis. In
this procedure, membrane-associated proteins are removed from
particles by incubating viruses with NP40/DTT, followed by the
separation of the soluble fraction from the insoluble portion by
centrifugation. During this procedure, the lateral bodies remain
associated with the insoluble fraction and thus core and lateral
body proteins are not discriminated from each other. To reﬁne this
analysis, virions attached to grids were treated using various
conditions and proteins associated with the particles were identi-
ﬁed by immunogold labeling. In parallel, virions were submitted to
the same treatments in suspension, the fractions were separated
by centrifugation and the proteins analyzed by western blot. A
typical result of a western blot analysis (A) and an immunogold
labeling of the viruses (B) is presented in Fig. 3. When viruses were
incubated in Tris–HCl only, none of the assayed proteins were
solubilized (Fig. 3A, Tris column). Upon treatment of the virions
with NP40, virus proteins A4 and A14 were partially removed from
the particle to the soluble fraction (Fig. 3A, NP column). However,
when DTT was added to the NP40 treatment, the membrane-
linked proteins A14 and A27 were completely removed from the
virions and moved to the soluble fraction (Fig. 3A, NPþDTT
column). The core proteins A4 and L4 were only partially removed
from the cores. When viruses were visualized by electron micro-
scopy after immunogold labeling of the proteins, the pattern of
protein labeling was consistent with the western blot analysis.
Immunolocalization of virus proteins A27 and A4 after the differ-
ent treatments is presented in Fig. 3B, a–c. Upon incubation with
either Tris buffer or NP40 alone, the membrane protein A27 was
immuno-localized on the surface of the particle but there was no
evidence for the presence of the core protein A4. When DTT was
combined with NP40 during the treatment of the particles, the
labeling of the A27 membrane protein disappeared from the
particles and the A4 core protein was now exposed. When the
assay was performed labeling proteins from the core wall (A10)
and lateral bodies (F17, H1), no labeling was observed when the
particles were treated with Tris buffer (Fig. 3B, d–f). Compared to
Tris buffer alone, in the presence of NP40, or NP40/DTT, increased
labeling of F17 was observed. The presence of the core protein A10
was observed only after treatment with NP40/DTT. When viruses
attached to the grids were incubated with in Tris buffer, followed
by immunogold labeling of the A14 membrane structural protein
and the H1 lateral body protein, gold particles present on the
virions were scarce (Fig. 3B, g–i). When NP40 was present in this
treatment, the presence of both A14 and H1 became more evident.
Combining DTT with the NP40 treatment, A14 was removed from
the particle but H1 continued to be attached to core. The EM data
are consistent with the western blot data and are consistent with
the interpretation that it is necessary to remove one layer of
proteins to expose the underlying layer of proteins. Speciﬁcally, in
untreated virions, only the external membrane protein A27 is
exposed to immunogold labeling. Treatment with NP40 alone,
which removes the lipid but leaves behind the membrane protein
array, retains A27 staining, and exposes the membrane structural
protein, A14, and the lateral body proteins F17 and H1. Treatment
with both NP40 and DTT removes the entire membrane including
the membrane protein array such that staining of membrane
proteins A14 and A27 is lost while staining for lateral body
proteins F17 and H1 is retained, and now the core proteins A4
and A10 are exposed to antibody.
Disrupting the virion core
Our initial attempts to detect the core proteins A3 and L4 on
intact, NP40 treated, or NP40þDTT treated virions were unsuc-
cessful (not shown). Because A3 is part of the core wall and L4 is a
DNA binding protein (Jesus et al., 2014), we hypothesize that these
proteins are located in the internal region of the core and are
therefore inaccessible to antibody using these procedures. We
therefore experimented with various treatments intended to
further strip or disrupt virion cores in order to expose internal
proteins. First, cores were prepared from VACV adsorbed to grids,
then further treated with various concentrations of DTT in the
absence or presence of 3 M NaCl. The incubation was followed
with a hypotonic shock, done by incubating the grids in deionized
water, before processing for negative staining (Fig. 4) or immuno-
gold labeling (Fig. 5). The extended incubation of cores in 10 mM
DTT (Fig. 4A) did not alter the morphology of the particle
compared with the initial NP40þDTT treatment (Fig. 1O). Increas-
ing the concentration of DTT to 100 mM partially disrupted the
core wall however the core still maintained its overall structure
(Fig. 4B). The addition of 3 M of NaCl to the incubation mixture in
the presence of 10 or 100 mM DTT did not disrupt the core (Fig. 4C
and D), although at higher DTT and NaCl concentrations the
external surface of the cores appears disordered. The fate of the
proteins associated with the lateral bodies and core was analyzed
after treatment with 100 mM DTT in the presence or absence of
3 M NaCl by western blot and immunogold labeling of the
particles (Fig. 5). The western blot shows that core proteins A10,
A3, and H1 continue to be attached to the cores (P) after treatment
with high DTT and NaCl (Fig. 5A). By contrast, the proteins A4
and F17 were partially removed from the core fraction to the
soluble fraction (S). Immunogold labeling for electron microscopy
demonstrated that after treatment with 3 M NaCl, cores were
depleted of the proteins F17 and A4 from the surface, but the
proteins A10 and H1 were still attached to the particle (Fig. 5B).
These results are consistent with previous observations suggesting
that A4 protein constitutes the palisade structure of the core wall
and showing that A4 interacts with the core wall protein A10
(Cudmore et al., 1996; Risco et al., 1999). Interestingly, the NaCl/
DTT treatment exposed some A3 on the surface of the core. The
exposure of A3 in the immunogold labeling could be due to the
partial removal of A4 from the core wall or to an increase in
permeability of core wall.
Although some A3 was observed after treatment with DTT-
NaCl, L4 was still undetectable (not shown). Because L4 is a DNA-
binding protein, it may be located in the interior of the core and
visualized only after rupture of the core wall.
Because the overall core integrity was relatively resistant to
action of various chemical agents, we tested whether a mild
treatment of the cores with protease could rupture the core and
expose the interior while nevertheless preserving a recognizable
core wall structure. Cores attached to the grids were incubated in
the presence of pronase E or papain and analyzed by electron
microscopy. As shown in Fig. 6, cores treated with pronase E
(Fig. 6B) or papain (Fig. 6C) preserve their brick shape, but the core
wall appears to be removed. Because the protease treatment was
done after the virus was attached to the grid, the strong interac-
tion between the particle and the carbon ﬁlm on the grid could
contribute to the maintenance of the shape of the virion. To
determine whether lateral body and core wall proteins are
removed upon protease treatment, the fate of F17 (Fig. 7A and B)
and A4 (Fig. 7C and D) was analyzed by immunogold labeling of
cores. As an indication of the degradation of the core wall, the
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release of DNA from the cores was assessed by immunogold
labeling. As shown in Fig. 7, proteins F17 and A4 are associated
with cores not treated with protease, and viral DNA was not
labeled within these cores. After treatment with pronase E, most
of the F17 and A4 proteins were digested from the cores and the
exposure of viral DNA on the grids was unmistakable. Because
digestion of the core wall exposed viral DNA, the presence of the
A3 and L4 proteins was investigated after protease treatment. As
shown in Fig. 8A and D, DNA, A3, and L4 were not detected on
cores not treated with proteases. However, after incubation with
pronase E (Fig. 8B) or papain (Fig. 8C) the A3 and DNA were easily
seen associated with the particle or released on the grid. Interest-
ingly, after the same treatment the presence of L4 was still not
evident (Fig. 8E and F).
Fig. 3. Analysis by Western blot and immunogold labeling of puriﬁed vaccinia virus after controlled degradation of virions. (A) Each lane contains the equivalent of 0.06
A260 nm units (0.7 mg) of virus that was incubated in different buffers as described in “Materials and methods” and labeled on the top of the ﬁgure. The presence of speciﬁc
proteins in the pellet (P) or supernatant (S) fractions was determined by Western blot and labeled on each lane. (B) Vaccinia virus was adsorbed on grids and incubated with
Tris (A, D, G), NP-40 (B, E, H), or NP-40þDTT (C, F, I) as described in “Materials and methods”. After this treatment, the proteins associated with the virions were identiﬁed by
immunogold labeling using the antibodies A27 (●) A4 (●) (A–C), A10 (●) F17 (●) (D–F), A14 (●) H1 (●) (G–I) as described in “Materials and methods”.
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Viruses mutant in the core wall protein A3 produce fragile particles
Vaccinia viruses with temperature sensitive mutations in the
A3L gene, one of the major core wall proteins, have been
previously characterized with respect to replication and morpho-
genesis (Kato et al., 2004). The electron microscopic analysis of the
mutants reveals formation of aberrant MV. Although puriﬁed
aberrant virions were indistinguishable from wt viruses in protein
composition, mutant virions are inactive in a permeabilized virion
transcription system. Whole mount preparation of puriﬁed A3
mutants Cts8 and Cts26 was analyzed by electron microscopy after
negative staining with NanoWor uranyl acetate (Fig. 9). A3 mutant
viruses incubated with buffer (Fig. 9A) present an altered mor-
phology when compared with wt viruses (Fig. 1A). In this
preparation only capsule-like particles were visualized, and virus
particles have a rounded form different from the brick/barrel
shape forms observed in wt viruses. In some particles, the core
appears to be dislocated from the center of the particle. Surpris-
ingly, after treatment of A3 mutant viruses with NP40þDTT the
virus core wall was ruptured and the internal contents released
(Fig. 9B, D, and E). When cores treated with NP40þDTT were
negative stained with NanoW (Fig. 9B), the internal material was
released as a tangled, bead-like structure. When NP40þDTT
treated cores were negative stained with UA, the material released
from the core spread on the grid with a reticulated appearance
while the cores seemed depleted their internal structure (Fig. 9D
and E). Because the major internal component of the core is the
viral genome, it is possible that the material released is DNA,
either naked or associated with proteins. To analyze whether DNA
was present in the released material, A3 mutants were adsorbed to
grids, treated with NP40/DTT, followed by incubation with DNase.
As shown Fig. 9C, in cores negative stained with NanoW the
tangled structure released from the core seems relatively resistant
to DNase. When cores were negative stained with UA after
incubation with DNase, the reticulated material was completely
removed suggesting that DNA is part of the released material. The
presence of viral proteins associated with the cores and the
released material was analyzed by immunogold labeling (Figs. 10
and 11). As shown above, in both wt (Fig. 10A) and A3 mutant
viruses (Fig. 10D) the core wall proteins A10 and A4 were easily
observed associated with the particle. By contrast, the core wall
protein A3 was not visible in wt virions (Fig. 10B) but exposed in
the mutant virus (Fig. 10E). Similar results were observed when
the presence of DNA was detected by immunogold labeling
(Fig. 10C and F). Speciﬁcally, the presence of DNA associated with
the particle was only observed in the mutant virus and not present
on the wt cores. Core wall proteins A10 (Fig. 10B and E) or A4
(Fig. 10C and F) were used as control for immunogold labeling and
could be observed in both preparations. Although in A3 mutant
viruses, internal proteins and DNA were exposed after treatment
with NP40/DTT, the presence of the DNA binding protein L4 was
still undetected. One possibility to be considered is that the L4
protein is wrapped in DNA in a nucleosome-like structure in a
conﬁguration that renders it unreactive to antibody. To evaluate
this possibility, mutants in A3 were treated with NP40þDTT and
incubated in the absence or presence of DNase (Fig. 11). In the
absence of DNase, virus DNA is released from the cores and as
previously observed, no L4 was detected (Fig. 11A). When cores
were incubated in the presence of DNase, the amount of immu-
nogold labeling of DNA decreased, and the L4 protein could be
Fig. 4. Morphological changes in vaccinia cores after high salt and high DTT treatment. Vaccinia cores prepared as described before were subjected to treatment with 10 mM
(A, C) or 100 mM (B, D) DTT in the absence (A, B) or presence (C, D) of 3 M NaCl and stained with Nano-W as described in “Materials and methods” before visualization
by TEM.
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Fig. 5. Analysis by Western blot and immunogold labeling of vaccinia cores after treatment with high salt. (A) The equivalent of 0.06 A260 nm units (0.7 mg) of virus that was
incubated in NP-40þDTT to prepare cores as described in “Materials and methods”. Cores were then incubated in buffer S (Cntl) or buffer SN (NaCl) as described in
“Materials and methods” and labeled on the top of the ﬁgure. The presence of speciﬁc protein in the pellet (P) or supernatant (S) fraction was determined by Western blot.
(B) Vaccinia virus was adsorbed on grids and incubated with NP-40þDTT to prepare cores as described in “Materials and methods”. After this treatment, the grids were
incubated in buffer S (A–D) or buffer SN (E–H) for 20 min, washed in ddH2O and proteins associated to the virions were identiﬁed by immunogold labeling using the
antibodies A10 (●) A4 (●) (A, E), A10 (●) F17 (●) (B, F), A10 (●) H1 (●) (C, G), A10 (●) A3 (●) (D, H) as described in “Materials and methods”.
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unmistakably identiﬁed (Fig. 11C). Interestingly, after incubation of
the cores with DNase, the presence of A3 protein was also
enhanced when compared to virus not treated with DNase
(Fig. 11B and D). It is possible that both L4 and A3 play a role on
the organization of the viral DNA inside the core.
Discussion
Advances in VACV genomics, proteomics, and genetics have
contributed to assigning proteins to speciﬁc genes in genome,
identifying proteins as constituents of the virus particle, and
understanding the role of these proteins in the replicative cycle.
Electron microscopy has also played an important role in compre-
hending several aspects of viral morphogenesis and poxvirus
virion structure (Condit et al., 2006; Cyrklaff et al., 2005;
Dubochet et al., 1994; Heuser, 2005; Moss, 2013; Pedersen et al.,
2000; Roos et al., 1996). Although all of these techniques have
played an essential role in understanding the biology of VACV, the
ﬁne details of the virion structure have yet to be determined. The
dissection of a complex viral structure such as VACV should be
achieved with the aid of chemical, enzymatic, and physical
Fig. 6. Morphological changes on vaccinia cores after protease treatment. Vaccinia cores prepared on the grids as described before were incubated in Tris (A), 2 mg/ml of
Pronase E (B) or 2 mg/ml Papain (C) for 120 min. After this period, the grids were negative stained with Nano-W as described in “Materials and methods” before visualization
by TEM.
Fig. 7. Vaccinia DNA is exposed after Pronase E treatment. Vaccinia cores prepared on the grids as described before were incubated in Tris (A, C) or 2 mg/ml of Pronase
E (B, D) for 120 min. After this treatment, the grids were washed in ddH2O and the DNA and proteins associated with the virions were identiﬁed by immunogold labeling
using the antibodies F17 (●) DNA (●) (A, B), A4 (●) DNA (●) (C, D) as described in “Materials and methods”.
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implements. These tools are employed in peeling off, layer by
layer, the intricate virus structure down to the nucleocapsid.
Several reports have described the use of non-ionic detergent to
remove the viral membrane lipid layer of VACV. When the non-
ionic detergent was combined with a reducing agent, the protein
array that is associated with the lipid layer was also extracted
Fig. 8. The A3 core protein and vaccinia DNA are exposed after protease treatment. Vaccinia cores prepared on the grids as described before were incubated in Tris (A, D), or
2 mg/ml of Pronase E (B, E), or 2 mg/ml of Papain (C, F) for 120 min. After this period, the grids were washed in ddH2O and the DNA and proteins associated with the virions
were identiﬁed by immunogold labeling using the antibodies A3 (●) DNA (●) (A–C), L4 (●) DNA (●) (D–F) as described in “Materials and methods”.
Fig. 9. Temperature sensitive mutant in the core wall protein A3 makes fragile particle under non-permissive conditions. Puriﬁed Cts8 virions grown at the non-permissive
temperature were adsorbed on a Formvar/carbon coated grid and incubated in the presence of Tris (A), or NP-40þDTT (B-F). After 20 min, the grids were washed, and two
were incubated with 40 mg/ml DNase (C, F), for 15 min. The grids were stained with Nano-W (A-C) or UA (D-F) as described in “Materials and methods”.
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(Boyd et al., 2010; Castro et al., 2003; da Fonseca et al., 2004;
Grifﬁths et al., 2001; Ichihashi et al., 1984; Nichols et al., 2008;
Pedersen et al., 2000; Resch and Moss, 2005; Roos et al., 1996;
Schmidt et al., 2013; Senkevich et al., 2008; Sood et al., 2008;
Townsley et al., 2005; Unger et al., 2008; Wallengren et al., 2001;
Wickramasekera and Traktman, 2010; Wilcock and Smith, 1996).
Proteins dissociated from the membrane complex can be analyzed
by western blot and the cores visualized by electron microscopy.
With these analyses, it was possible to determine that most of the
membrane-associated proteins were involved in the attachment
and entry-fusion complex necessary for virus infection (Carter
et al., 2005; Moss, 2006, 2012; Roberts and Smith, 2008). In this
work we showed when VACV particles were treated with NP40,
membranes proteins A27 and A14 became more exposed to the
antibodies, and when DTT was added to the treatment these
proteins are removed from the remaining cores. Because A27 is
part of the attachment complex and A14 is one of the major
components of the membrane complex, treating viruses with
NP40 and DTT will remove the lipids and the protein array from
the particle, exposing proteins from lateral bodies and core (Carter
et al., 2005; Ching et al., 2009; Cudmore et al., 1996; Mercer and
Traktman, 2003; Moss, 2012; Rodriguez et al., 1987; Unger et al.,
2013).
One of the most intriguing features in poxvirus structure is the
origin and composition of the lateral bodies. Lateral bodies are
amorphous structures located between the viral membrane and
the core wall, and have only been described using electron
microscopy (Condit et al., 2006). Although the nature of the lateral
bodies has intrigued poxvirologists for many years, the absence of
adequate tools has delayed the understanding of these structures.
One possible function of the proteins in the lateral bodies is to play
a role in virus–host interaction, helping the virus to escape innate
cellular antiviral defenses. In this case, the lateral bodies would
have a role similar to the tegument in the Herpesviridae (Kalejta,
2008; Kelly et al., 2009; Tomtishen, 2012). In HSV, the tegument
occupies the space between the capsid and the envelope and
consists of at least 20 viral encoded proteins. Different properties
and functions have been assigned to tegument proteins such as
proteins kinases, interferon inhibitors, apoptosis and host transla-
tion regulators. Some of these proteins are conserved in the
Herpesvirinae subfamily. Among the approximately 70 virion
proteins associated with puriﬁed VACV MV, nearly 20 virus
proteins are located in the membrane, three proteins form the
core wall, and 22 proteins constitute the transcription apparatus
and nucleocapsid (Chung et al., 2006; Matson et al., 2014; Resch
et al., 2007; Yoder et al., 2006). Thus the location of at least 25
proteins is still unknown. Most of these proteins could be forming
the lateral bodies or could be located in another sub-domain of the
virion. In this list, we include virus proteins with a known function
such as: protein kinase (F10), Tyr/Ser protein phosphatase (H1),
cysteine proteinase (I7); the complex of seven proteins that are
involved in the formation of the MV; and proteins involved in the
formation of disulﬁde bonds in intracellular virion membrane
proteins (Schmidt et al., 2013; Senkevich et al., 2002; Szajner
et al., 2004; Traktman et al., 1995; Wickramasekera and Traktman,
2010). Other proteins have been proposed to be constituent of the
lateral bodies and could be involved in virus–host interactions.
Among these is the essential protein F17. F17 is the second most
abundant protein in the virion, it is phosphorylated by cellular
kinases, and interacts with A30, one of the 7-protein complex
Fig. 10. The core wall protein A3 and DNA are released from the virions after controlled degradation of A3 mutants. Puriﬁed wt virions (A–C) and puriﬁed Cts8 virions grown
at non-permissive temperature were adsorbed on Formvar/carbon coated grids and incubated in the presence of NP-40þDTT. The grids were then washed in ddH2O and the
DNA and proteins associated with the virions were identiﬁed by immunogold labeling using the antibodies A10 (●) A4 (●) (A, D), A10 (●) A3 (●) (B, E), A4 (●) DNA (●) (C, F) as
described in “Materials and methods”.
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(Wickramasekera and Traktman, 2010). Mutation of the cellular
phosphorylation site in F17 does not affect virion morphogenesis
but reduces the infectivity of the progeny. It has been sugested
that after VACV entry F17 is degraded in a proteasome-dependent
manner (Schmidt et al., 2013). Interestingly, the fact that F17
interacts with A30 suggests by association that the seven protein
complex may be localized to the lateral bodies. This would be
consistent with a role for the seven protein complex which is
forming the initial association between viroplasm and membranes
during virion morphogenesis (Szajner et al., 2004). Proteins such
as L3, E6, and E8 are located in the virions and have an important
role in VACV replication (Boyd et al., 2010; Kato et al., 2007; Resch
and Moss, 2005). These proteins contain no known motifs or other
features that provide an indication of their role in the virus
replicative cycle. These proteins do not appear to be transcription
factors but in their absence cores are inactive in synthetizing RNA.
Finally, the VACV proteins G5 and G6 have been shown to be
present in puriﬁed MV (da Fonseca et al., 2004; Senkevich et al.,
2008). G5 belongs to the FEN1-like family of nucleases, and it is
conserved in all poxviruses (Senkevich et al., 2009). G6 belongs to
the NlpC/P60 superfamily, contributes to the virus virulence, and
localizes to the lateral bodies. Interestingly, neither G5 nor G6 has
been identiﬁed in any of the published proteomic studies. Because
in these studies G5 and G6 were expressed under a T7 operator it
is possible that under these conditions both proteins were over-
expressed and passively encapsidated by the virions (Franke and
Hruby, 1987; Gomez and Esteban, 2001). We showed that the
treatment of cores with higher a concentration of 100 mM DTT and
3 M NaCl could remove proteins from the surface of the core while
preserving its structure. In our assay, F17 and A4 were partially
removed after this treatment, while A10 and H1 were still attached
to outside structure the cores. It is possible that proteins of the
lateral bodies function not only as a connecting structure between
the membrane and core wall but also as mediator of infection.
Application of the techniques described here to the analysis of
additional proteins of unknown location may aid in elaborating
the contents of the lateral bodies.
The VACV core wall is composed of at least three viral-encoded
proteins that form a very tight structure (Condit et al., 2006; Moss,
2013). Presumably, A3 is located in the internal part of the core
wall; A10 and A4 are positioned in the external part of the wall;
and the molecular ratio of these proteins is 1:1:10 respectively
(Chung et al., 2006; Ichihashi et al., 1984). A4 lays on the external
part of the core wall, forming palisade-like structures (Cudmore
et al., 1996; Roos et al., 1996). In accordance with this model are
our results with the immunogold labeling of A4, where the gold
particles uniformly decorate the exterior of the core wall. The
partial removal of A4 from the core wall after NaCl/DTT treatment
was unexpected because this protein forms a stable complex with
A10 that was not removed during the procedure (Chung et al.,
2006; Risco et al., 1999). Interesting, after NaCl/DTT and hypertonic
shock the core wall protein A3 could be visualized by immunogold
labeling, suggesting that after peeling off the A4 layer, the A3 layer
became visible. The presence of a pore-like structure on the core
wall that was observed in our negative staining approach has been
ﬁrst reported in the cryo-electron tomographic reconstruction of
VACV (Cyrklaff et al., 2005). This pore-like structure seems to
traverse the core wall, communicating internal and external
milieu, and could be formed by one or more core wall proteins
or by the insertion of another viral protein. One of the possible
functions of the pore-like structure is in the extrusion of the newly
transcribed early mRNA from the core to be translated by the
Fig. 11. L4 protein can be visualized only after DNase treatment. Puriﬁed Cts8 virions grown at the non-permissive temperature were adsorbed on Formvar/carbon coated
grids and incubated in the presence of NP-40þDTT. After 20 min, the grids were washed, and not treated (A, B) or treated with 40 mg/ml DNase (C, D). After this period, the
grids were washed in ddH2O and the DNA and proteins associated to the virions were identiﬁed by immunogold labeling using the following antibodies L4 (●) DNA (●) (A, C),
A3 (●) DNA (●) as described in “Materials and methods”.
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cellular ribosomes (Gross and Shuman, 1996; Kates and Beeson,
1970). The pore-like structures could also function in the intake of
nucleotides or other molecules into the core milieu.
During the course of infection, the VACV cores undergo a second
uncoating process to release its genome for replication, in a
mechanism that is still only partially understood (Dales, 1963;
Joklik, 1964a, 1964b; Kilcher et al., 2014; Moss, 2013). This step is
dependent on virus early proteins, and cellular enzymes could be
involved. In a manner similar to that which occurs with the release
of proteins from the lateral bodies, a proteasome-mediated step
could be engaged in disassembling the core wall, a mechanism that
has been described with other viruses (Horan et al., 2013; Lopez
et al., 2011; Schmidt et al., 2013). All our attempts to break the core
wall using different detergents were unsuccessful (data not shown).
The core wall was resistant to different non-ionic detergents, and in
the presence of ionic detergents, the cores were solubilized beyond
recognition as has been shown before (Soloski et al., 1979; Soloski
and Holowczak, 1981). Because chemical and physical treatment
failed to disrupt the core wall, we switch to a mild protease
treatment to disrupt the core wall. Under these conditions, we
were able to expose the internal part of the core wall preserving the
overall structure of the core. The removal of the core wall enables
the labeling of A3 and the virus DNA. Interestingly, the L4 protein
was not consistently visualized with this approach. The identiﬁca-
tion of L4 protein was only achieved when we used A3
temperature-sensitive mutant viruses. When these mutants were
grown at non-permissive temperature, aberrant virus particles were
formed. Once these puriﬁed particles were treated with NP40 and
DTT the core wall burst open releasing the DNA and proteins to the
exterior. Using these mutants, we were able to show that L4 protein
wraps DNA around itself, in a nucleosome-like structure (Smith,
1991; Turner, 2014). The packaging of the virus genome in a
nucleosome-like manner could explain the tubular nucleocapsid
structure observed in EM sections or with negative staining of the
particle with PTA (Heuser, 2005; McFadden et al., 2012; Muller and
Peters, 1963; Peters and Muller, 1963).
Combining our results with published data some considera-
tions emerged that will help us understand the structure of the
virus. In the whole mount approach, VACV can appear in both the
mulberry-like or capsule-like forms (Easterbrook, 1966; Muller
and Peters, 1963; Peters and Muller, 1963; Westwood et al., 1964).
The difference between these two forms is related mainly to the
integrity of the particle. Damage to the viral membrane permits
the penetration of the stain and results in the altered the
appearance of the particle (Harris and Westwood, 1964). Treat-
ment of VACV with NP40 also damages the particle by removing
the lipid layer but preserves the protein array associated with the
virion. In this situation, the stain penetrates the particle and all
virions have now a capsule-like form. These two forms of VACV
can also be differentiated by their size, because the capsular virion
has larger dimensions than the mulberry form as has been shown
here and by others (Westwood et al., 1964). Our data have also
shown that after NP40 treatment virions were enlarged and their
dimensions were now similar to the capsule-like particles. It is also
important to mention that cores increase in size after being
released inside the cell (Cyrklaff et al., 2007; Schmidt et al.,
2013). The change in size of VACV can be viewed in a broader
perspective. The ﬁrst change in volume of the viral particle occurs
during virion morphogenesis during the IV to MV transition. In
this stage, the spherical IV particles are transformed into the brick/
barrel shape of mature virions and their dimensions are signiﬁ-
cantly reduced (Chichon et al., 2009; Condit et al., 2006). It is
possible that during this contraction step, water would be
excluded from the internal milieu of the cores, and consequently
the internal structures of the virion would contract including
nucleocapsid that would condense forming the tubular-like struc-
ture previously described (Condit et al., 2006; Heuser, 2005;
McFadden et al., 2012; Peters and Muller, 1963). MV in the
mulberry-like form would be impermeable to water, and after
losing the membrane during the entry process rehydration of the
internal milieu would occur, and an increase in the size of the
particle and unfolding of the nucleocapsid would follow. We can
also speculate that the rehydration of the internal component is
required for virus activation. In Fig. 12, we show representations of
the VACV MV in the three conditions described above. The
mulberry form of the virus is represented with the intact
Fig. 12. A model for vaccinia virus structure. (A) Last steps of morphogenesis starting with immature virion (IV), followed by the incorporation of a DNA molecule to form the
immature virions with nucleoid (IVN) and the proteolysis of speciﬁc proteins to form the mature virion (MV). (B) Fine detail of a sagittal section (see inset, lower left) of the
MV showing the different virion sub-domains as speciﬁed on the left side of the ﬁgure. (C) Same as B but the virions were treated with NP-40 and the virion lose the lipid
content. (D) Same as B but the virions were treated with NP-40þDTT and the virus loses the lipids and the membrane proteins.
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membrane containing the lipid layer and protein array. In this
situation, the virus is impermeable, the lateral bodies are com-
pacted, and nucleocapsid is condensed. The core wall is repre-
sented by the three protein layers and the pore-like structure
spanning the wall. Upon the removal of the lipid layer by NP40
treatment, there is an expansion of virion structure including the
lateral bodies. In this situation, the protein array is still present but
the nucleocapsid is no longer condensed. Upon incubation of
virions with NP40þDTT in vitro or after virus penetration into
cells in vivo both the lipid layer and the protein array are lost,
lateral bodies are enlarged, and nucleocapsid expands.
The structure of the virion capsid is fundamental to the survival
of viruses before infecting the host cell. The formation of the
capsid is essential to protect the genome against changes in the
environment such as pH, temperature, tonicity of the milieu or
other conditions that could damage infectivity. It has been shown
that in some viruses the genome is packed under high pressure
that is necessary the delivery of the DNA into the infected cell
(Bauer et al., 2013; Evilevitch et al., 2011; Roos et al., 2007). These
viruses inject DNA directly into the cell and the viral capsid
remains in the outside the cell (prokaryotes) or they inject DNA
into the nucleus following transport of capsids through the
cytoplasm (eukaryotes). Packing the genome at high pressure
could be a way to protect the genome and deliver the DNA in an
efﬁcient manner. In VACV, the dehydration of the internal milieu
may be a mechanism of protecting the genome. After virus entry,
core will become permeable to water, and after hydration the
nucleocapsid will acquire a relaxed form that will be now favor-
able to transcription. This phenomenon could be a general
mechanism for viruses that contain a transcription apparatus
associated with the particle and that require the removal of the
membrane or capsid to be activated (Joklik, 1980, 1981; Lopez
et al., 2011; Skehel and Joklik, 1969).
Materials and methods
Virus and cells
Wild-type vaccinia virus WR strain and temperature mutants
Cts8 and Cts26 (Kato et al., 2004) were used in this work. Viruses
were grown in BSC40 cells, an African green monkey cell line, and
the puriﬁcation procedure has been described before (Ausubel
et al., 1994; Kato et al., 2004).
Preparation of vaccinia cores for high salt treatment
Virus cores were prepared by incubating 0.1 A260 nm units of
virus in 100 ml of core buffer (50 mM Tris–HCl pH 8.0, 10 mM DTT,
0.05% NP40) for 10 min at room temperature. The cores were
collected by a 5 min centrifugation in an Eppendorf microfuge and
resuspended in 50 ml of a buffer containing 50 mM Tris–HCl, pH
8.0, 0.5% NP40, 100 mM DTT, in the absence (buffer S) or presence
of 3 M NaCl (buffer SN). After 20 min incubation on ice, 3 volumes
of ddH2O and 30 mg of glycogen were added to the reaction and
soluble and insoluble fractions were separated by 30 min centri-
fugation at 20,000 g through a 30 ml 10% sucrose cushion in an
Eppendorf microfuge. The pellet was resuspended in 100 ml SDS
sample buffer. The supernatant fraction was adjusted to a ﬁnal
concentration of 0.1 M sodium acetate, pH 5.2. Three volumes of
ethanol were added and the sample incubated for 2 h at 20 1C.
The sample was centrifuged for 30 min at maximum speed in an
Eppendorf microfuge. The supernatant was discarded and the
pellet resuspended in 100 ml SDS sample buffer. The samples were
subjected to western blot analysis as described below.
Western blot analysis
Virion fractions were prepared by incubating 0.1–0.15 A260 nm
units (6.8–10 mg) of wt particles in a 300 ml volume of either Tris
buffer (50 mM Tris–HCl pH 8.0), NP buffer (0.5% NP40 in 50 mM
Tris–HCl pH 8.0) or NPþDTT buffer (50 mM DTT, 0.5% NP40 in
50 mM Tris–HCl pH 8.0), for 20 min at 37 1C. The fractions were
separated by centrifugation through 30 ml of a 10% sucrose cushion
for 20 min at maximum speed in an Eppendorf microfuge. 330 ml of
supernatant fraction was removed and the pellet was resuspended
in 330 ml of 50 mM Tris–HCl, pH 8.0. 60 ml of 5 SDS-sample buffer
was added to the pellet and supernatant fractions. The proteins in
each fraction were separated by an 11% SDS-PAGE, transferred to a
nitrocellulose membrane and processed for Western blot analysis as
described previously (Boyd et al., 2010). The membrane was
blocked with a solution of TBS-T (50 mM Tris–HCl pH 7.5;
150 mM NaCl; 0.01% Tween 20) and 5% non-fat dry milk (TBS-TM)
for 1 h, and then incubated with an appropriate dilution of the
primary antibody in TBS-TM overnight at 8 1C. The membrane was
washed 5 times for 10 min with TBS-T and incubated with a
horseradish peroxidase conjugated secondary antibody (Santa Cruz
Biotechnology) diluted in TBS-TM for 2 h at 8 1C. The membrane
was washed 5 times for 10 min and the protein complex detected
by chemiluminescence (GE Healthcare). The dilution and source of
the primary antibodies were anti-A3 (1:20,000) rabbit serum
supplied by Dr. Bernard Moss (NIAID); anti-A4 (1:20,000) and
anti-A10 (1:20,000) rabbit serum supplied by Dr. Mariano Esteban
(Universidad Autónoma, Madrid); anti-A10 (1:2000) monoclonal
antibody supplied by Dr. Yan Xiang (University of Texas); anti-A14
(1:1000), anti-F17 (1:20,000) and anti-H1 (1:1000) rabbit serum
supplied by Dr. Paula Traktman (Medical College of Wisconsin);
anti-A27 (1:10,000) monoclonal antibody supplied by Dr. David
Ulaeto (Dstl Porton Down, Salisbury); and anti-L4 (1:40,000) rabbit
serum supplied by Dr. Dennis Hruby (Oregon State University);
dsDNA monoclonal antibody (1:50) clone HYB331-01, Santa Cruz
Biotechnology; immunogold conjugate goat anti-rabbit and goat
anti-mouse antibody (1:50) British Biocell International (BBI).
Negative staining of vaccinia virus
5–7 ml of puriﬁed virions (1.2109 particles) was adsorbed on a
Formvar/carbon-coated nickel grid (EMS—USA) for 10 min at room
temperature. The grids were then washed with 10 mM Tris–HCl,
pH 8.0 and incubated for 20 min in the presence of Tris, NP, or
NPþDTT buffers described above. The grids were then washed for
5 min with 10 mM Tris–HCl, rinsed with ddH2O and stained for
2 min with one of the following solutions: 3% phosphotungstic
acid (PTA) pH 7.0, 3% phosphotungstic acid (PTA) pH 10.5, 3%
ammoniummolybdate (AmMo) pH 7.0, 1% uranyl acetate (UA), and
Nano-W (2% methylamine tungstate pH 6.8, Nano Probes). The
grids were dried and the samples were viewed in a Hitachi H7000
transmission electron microscope (TEM). As described in the text,
in some experiments grids were incubated with in buffers S or SN,
Pronase E (Sigma-Aldrich) or Papain (Sigma Aldrich) or DNase
(Sigma Aldrich) before the negative staining or immunogold
labeling. For the rotatory shadowing of the sample, the dried grid
was loaded into a Bal-Tec Med030 metal evaporator equipped with
C-Pd E-guns. Low angle rotary shadow was carried out at 51 angle
and 100 RPM (Hendricks, 2014). The virus was imaged on a Hitachi
H-7000 transmission electron microscope, with assistance of the
University of Florida ICBR Electron Microscopy Core Laboratory.
Immunogold labeling of vaccinia proteins
For the identiﬁcation of virion proteins associated with the
particles, virions attached to grids and treated as described above
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were incubated in blocking solution (3% albumin—Sigma Aldrich)
for 30 min at room temperature. When treating virion particles
previously exposed to NP40, 0.1% NP40 (USB) was added to the
blocking solution to reduce the background. The grids were then
incubated with antibody mixture diluted in blocking solution (see
ﬁgure legend) and incubated overnight at 4 1C. The grids were
then washed twice for 10 min each in PBS-EM (10.4 mM Na2HPO4,
3.2 mM KH2PO4, and 150 mM NaCl, pH 7.4), then incubated for
10 min in blocking solution and then incubated with the gold
conjugated antibody for 3 h at room temperature. The grids were
then washed twice for 10 min each in PBS-EM, ﬁxed with McDo-
well Trumps ﬁxative (EMS) (1% glutaraldehyde, 4% formaldehyde
in 0.1 M Na2HPO4 buffer, pH 7.2) diluted 1:4, washed in water for
5 min, stain for 5 min with Nano-van (2% methylamine vanadate
(Nano Probes), and dried before observing in the TEM.
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